Agrigenomics Market

By Technology;

Real-Time PCR (qPCR), Microarrays, Next-Generation Sequencing (NGS), Capillary Electrophoresis and Others

By Sequencer Type;

Illumina HiSeq & NovaSeq, PacBio & Oxford Nanopore, Sanger Sequencers, SOLiD and Others

By Application;

Crops and Livestock

By Service Offering;

Genotyping, DNA Fingerprinting, Genetic Purity Assessment, Trait Purity Assessment and Gene Expression Analysis

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn359544466 Published Date: October, 2025 Updated Date: November, 2025

Agrigenomics Market Overview

Agrigenomics Market (USD Million)

Agrigenomics Market was valued at USD 4,216.11 million in the year 2024. The size of this market is expected to increase to USD 7,907.40 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.4%.


Agrigenomics Market

*Market size in USD million

CAGR 9.4 %


Study Period2025 - 2031
Base Year2024
CAGR (%)9.4 %
Market Size (2024)USD 4,216.11 Million
Market Size (2031)USD 7,907.40 Million
Market ConcentrationMedium
Report Pages311
4,216.11
2024
7,907.40
2031

Major Players

  • Agilent Technologies' Inc
  • Thermo Fisher Scientific, Inc
  • technologies from Illumina, Inc
  • Illumina' Inc
  • Zoetis' Inc

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Agrigenomics Market

Fragmented - Highly competitive market without dominant players


The Agrigenomics Market applies genomic science to enhance crop and livestock traits through sequencing, genotyping, and selection indices. More than 45% of breeding programs now use DNA-informed decisions, with omics-led discovery present in 50% of trials and yield improvements of 10–20% where genomic selection is embedded.

Acceleration in Breeding Efficiency
Use of high-throughput genotyping compresses cycles by 30–40%, while tighter phenotype–genotype mapping lifts selection accuracy by 15–25%. Over 55% of pipelines integrate bioinformatics dashboards and sample automation; data compliance rates exceed 60%, cutting manual errors by 20–30% across critical steps.

Converging Tools and Platforms
With sequencing costs down by more than 70%, access to whole-genome and panel-based assays is expanding. Around 50–60% of implementations now include AI/ML variant calling and trait modeling, and edge-enabled labs handle 25–35% of runs. Cloud-native orchestration supports 65% of new builds, boosting throughput by 30–45%.

Insight-Driven Farm Decisions
Adoption of multi-omics analytics strengthens trait heritability signals by 20–35%, with predictive accuracy lifting 15–20% in early selections. Use of GEBVs surpasses 50%, while harmonized SNP panels and reference datasets raise QC pass rates by 25–30%, improving breeding confidence and portfolio ROI.

Forward Trajectory and Value Creation
Planned investments show 60–65% of organizations increasing spend on automation, AI analytics, and genotype–phenotype platforms. Programs forecast time-to-variety reductions of 20–30% and input-use efficiency gains of 10–15%, underscoring durable momentum as collaborative R&D scales and IP pipelines deepen.